Literature DB >> 22897745

Recent advances in the role of probiotics in human inflammation and gut health.

Prithy Rupa1, Yoshinori Mine.   

Abstract

The gastrointestinal (GI) tract provides residence to an astounding number of bacterial species, which have profound effects on host biology, function, physiology, and immune response. Discovery of "symbiosis factors" from symbionts that facilitate the peaceful coexistence of microbiota and the host immune system are of interest. Symbionts synthesize immunomodulatory molecules that guide maturation of the immune system and have pivotal roles in many biological processes; however, individuals differ in the makeup of their GI microbiota, which is influenced by many external and internal factors such as diet, antibiotic use, and host genetics, which in turn influences health and disease outcomes. Various endogenous, genetic, and environmental factors influence GI development including species composition and health status of neonates, resulting in interactions that occur between the bacteria and the host. Mechanisms of probiotics involved in homeostasis of a balanced immune system have been inconclusive. The probable mechanism of action may be postulated as direct competition between pathogenic bacteria in the gut and/or immune modulation. This review focuses on probiotics in health and disease prevention, especially the biological importance of intestinal regulation of inflammatory processes that may be beneficial in a multitude of disorders both inside and outside the GI tract.

Entities:  

Mesh:

Year:  2012        PMID: 22897745     DOI: 10.1021/jf301903t

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  15 in total

1.  The Effects of Probiotic Honey Consumption on Metabolic Status in Patients with Diabetic Nephropathy: a Randomized, Double-Blind, Controlled Trial.

Authors:  Navid Mazruei Arani; Zahra Emam-Djomeh; Hamid Tavakolipour; Reza Sharafati-Chaleshtori; Alireza Soleimani; Zatollah Asemi
Journal:  Probiotics Antimicrob Proteins       Date:  2019-12       Impact factor: 4.609

2.  Effects of Bifidobacterium supplementation on intestinal microbiota composition and the immune response in healthy infants.

Authors:  Bing-Bing Wu; Yi Yang; Xiu Xu; Wei-Ping Wang
Journal:  World J Pediatr       Date:  2015-04-06       Impact factor: 2.764

3.  Recovery of Viable Bacteria from Probiotic Products that Target Oral Health.

Authors:  Jeffrey A Banas; Eric T Popp
Journal:  Probiotics Antimicrob Proteins       Date:  2013-09       Impact factor: 4.609

4.  From the Cover: Aloin, a Component of the Aloe Vera Plant Leaf, Induces Pathological Changes and Modulates the Composition of Microbiota in the Large Intestines of F344/N Male Rats.

Authors:  Mary D Boudreau; Greg R Olson; Volodymyr P Tryndyak; Matthew S Bryant; Robert P Felton; Frederick A Beland
Journal:  Toxicol Sci       Date:  2017-08-01       Impact factor: 4.849

5.  Genome Sequence of Lactobacillus rhamnosus Strain CNCM I-3698.

Authors:  R Tareb; M Bernardeau; J P Vernoux
Journal:  Genome Announc       Date:  2015-06-11

6.  Characterization and in vitro properties of oral lactobacilli in breastfed infants.

Authors:  Nelly Romani Vestman; Niklas Timby; Pernilla Lif Holgerson; Christine A Kressirer; Rolf Claesson; Magnus Domellöf; Carina Öhman; Anne C R Tanner; Olle Hernell; Ingegerd Johansson
Journal:  BMC Microbiol       Date:  2013-08-15       Impact factor: 3.605

7.  Physiological Properties and Salmonella Growth Inhibition of Probiotic Bacillus Strains Isolated from Environmental and Poultry Sources.

Authors:  Anita Menconi; Marion J Morgan; Neil R Pumford; Billy M Hargis; Guillermo Tellez
Journal:  Int J Bacteriol       Date:  2013-05-26

8.  Integrated Role of Bifidobacterium animalis subsp. lactis Supplementation in Gut Microbiota, Immunity, and Metabolism of Infant Rhesus Monkeys.

Authors:  Xuan He; Carolyn M Slupsky; James W Dekker; Neill W Haggarty; Bo Lönnerdal
Journal:  mSystems       Date:  2016-11-29       Impact factor: 6.496

9.  Carvacrol and trans-cinnamaldehyde reduce Clostridium difficile toxin production and cytotoxicity in vitro.

Authors:  Shankumar Mooyottu; Anup Kollanoor-Johny; Genevieve Flock; Laurent Bouillaut; Abhinav Upadhyay; Abraham L Sonenshein; Kumar Venkitanarayanan
Journal:  Int J Mol Sci       Date:  2014-03-12       Impact factor: 5.923

10.  Ginsenosides Rb3 and Rd reduce polyps formation while reinstate the dysbiotic gut microbiota and the intestinal microenvironment in ApcMin/+ mice.

Authors:  Guoxin Huang; Imran Khan; Xiaoang Li; Lei Chen; Waikit Leong; Leung Tsun Ho; W L Wendy Hsiao
Journal:  Sci Rep       Date:  2017-10-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.